Department of Medicine
Joel Pekow’s clinical research on inflammatory bowel disease (IBD) investigates mechanisms that lead to colon cancer in IBD patients. He is interested in using novel molecular methods to provide significant insights into why cancers develop in this population. He is also working to develop less invasive indicators of precancerous lesions and ways to block molecular changes in order to prevent cancer in IBD patients.
Pekow has received numerous honors including membership in the Sigma Xi National Scientific Honor Society (1998); membership in Alpha Omega Alpha, University of Illinois College of Medicine (2002); the Charles Spencer Williamson Award for Excellence in Internal Medicine, University of Illinois College of Medicine (2003); chief fellow, University of Chicago, Section of Gastroenterology (2008–09); and Fellows Research Award in IBD, Crohn’s Disease Working Group (2009).
Pekow is affiliated with the American Medical Association, American College of Physicians, American Gastrointestinal Association, American College of Gastroenterology, American Association of Liver Disease, and American Society for Gastrointestinal Endoscopy. He holds an MD from the University of Illinois College of Medicine and a BA in Latin American history and biology from Brown University.
Pekow joined the University of Chicago faculty in 2010.